RECURRENT MELANOMA
Clinical trials for RECURRENT MELANOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MELANOMA trials appear
Sign up with your email to follow new studies for RECURRENT MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on hard-to-treat melanoma in early trial
Disease control Recruiting nowThis early-phase study tests a new type of cell therapy for people with advanced melanoma that has not responded to standard treatments. The therapy uses a patient's own immune cells (NK cells) that have been engineered to recognize and attack a protein called PRAME found on mela…
Matched conditions: RECURRENT MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:53 UTC
-
New combo therapy aims to shrink tough cancers using biomarker clues
Disease control Recruiting nowThis study tests two drugs—cabozantinib and nivolumab—in people with advanced melanoma or head and neck cancer that has stopped responding to other treatments. The goal is to see if the combination can shrink or stabilize the cancer, and whether certain tumor biomarkers can predi…
Matched conditions: RECURRENT MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 06:49 UTC